Bacterial persisters: from mechanism modules to target prioritization and inhibitor development

Area of Science:

• Microbiology
• Infectious Diseases
• Drug Discovery

Background:

• Persister cells are dormant bacterial subpopulations that survive antibiotic treatment through reversible metabolic stasis.
• These persisters contribute to persistent and recurrent infections, posing significant public health challenges.
• Current antibiotic therapies are often ineffective against persisters, necessitating the development of novel therapeutic strategies.

Purpose of the Study:

• To systematically review the mechanisms underlying bacterial persister formation.
• To propose a framework for prioritizing therapeutic targets against persisters.
• To discuss strategic approaches and experimental platforms for developing effective persister-targeting inhibitors.

Main Methods:

• Systematic literature review of persister formation mechanisms.
• Development of a target-prioritization framework.
• Proposal of an evidence-grading scheme for evaluating therapeutic candidates.
• Discussion of strategic approaches and experimental validation platforms.

Main Results:

• Identified key mechanisms driving bacterial persister formation.
• Established a framework to differentiate early research findings from clinically relevant therapeutic targets.
• Outlined criteria for robust experimental validation of potential drug targets.

Conclusions:

• Understanding persister formation is crucial for developing effective treatments.
• A systematic approach to target selection and validation is needed to advance therapeutic development.
• This work provides a roadmap for guiding the rational design of novel therapies to reduce infection relapse and improve cure rates.